[1]张 雅,杨春荣,袁 峰,等.子痫前期孕妇血清hTERT 和Sirt6 水平表达与疾病严重程度及妊娠结局评估中的价值研究[J].现代检验医学杂志,2024,39(03):142-146+188.[doi:10.3969/j.issn.1671-7414.2024.03.024]
　ZHANG Ya,YANG Chunrong,YUAN Feng,et al.Study on the Serum hTERT and Sirt6 Level Expression and the Evaluation Value of Disease Severity and Pregnancy Outcome in Preeclampsia Pregnant Women[J].Journal of Modern Laboratory Medicine,2024,39(03):142-146+188.[doi:10.3969/j.issn.1671-7414.2024.03.024]
点击复制

子痫前期孕妇血清hTERT 和Sirt6 水平表达与疾病严重程度及妊娠结局评估中的价值研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第39卷
期数:
2024年03期
页码:
142-146+188
栏目:
论著
出版日期:
2024-05-15

文章信息/Info

Title:
Study on the Serum hTERT and Sirt6 Level Expression and the Evaluation Value of Disease Severity and Pregnancy Outcome in Preeclampsia Pregnant Women
文章编号:
1671-7414（2024）03-142-06
作者:
张 雅; 杨春荣; 袁 峰; 韩 曦; 刘晓红
（陕西省人民医院产科，西安 710068）
Author(s):
ZHANG Ya; YANG Chunrong; YUAN Feng; HAN Xi; LIU Xiaohong
（Department of Obstetrics and Gynecology，Shaanxi Provincial People’s Hospital，Xi’an 710068，China）
关键词:
子痫前期; 人端粒酶反转录酶; 沉默信息调节因子6; 妊娠结局
分类号:
R714.244；R392.11
DOI:
10.3969/j.issn.1671-7414.2024.03.024
文献标志码:
A
摘要:
目的 检测子痫前期孕妇血清中人端粒酶反转录酶（human telomerase reverse transcriptase，hTERT）、沉默信息调节因子6（silent information regulator 6，Sirt6）表达，并探究hTERT，Sirt6 水平表达与疾病严重程度及妊娠结局评估中的价值。方法 选取2018 年1 月～ 2022 年12 月在陕西省人民医院进行诊治的300 例子痫前期孕妇作为子痫前期组，孕妇均符合《妊娠期高血压疾病诊治指南（2015）》中子痫前期诊断标准，选取同时期孕检的300 例健康孕妇为对照组，根据病情严重程度将子痫前期组分为轻症子痫前期组（n=180）和重症子痫前期组（n=120），根据是否发生不良妊娠结局将子痫前期组分为正常妊娠组（n=165）和不良妊娠组（n=135）。酶联免疫吸附实验（enzyme-linked immunosorbnent assay，ELISA） 法检测血清中hTERT 和Sirt6 水平，Spearman 相关性分析血清中hTERT 和Sirt6 水平与子痫前期孕妇病情严重程度的相关性，利用受试者工作特征（receiver operating characteristic，ROC）曲线评估血清hTERT 和Sirt6 水平在子痫前期诊断及妊娠结局预测中的价值。结果 与对照组比较，子痫前期组血清hTERT（22.15±5.82 ng/ml vs 30.12±9.56 ng/ml），Sirt6（5.26±1.62 ng/ml vs 7.06±2.29 ng/ml） 水平降低，差异具有统计学意义（t=12.334，11.114，均P ＜ 0.001）。与轻症子痫前期组比较，重症子痫前期组孕妇血清hTERT（18.28±4.11 ng/ml vs 24.73±6.96 ng/ml），Sirt6（4.03±1.17 ng/ml vs 6.08±1.92 ng/ml）水平降低，差异具有统计学意义（t=9.142，10.469，均P ＜ 0.001）。与正常妊娠组比较，不良妊娠组子痫前期孕妇血清中hTERT（17.75±4.61 ng/ml vs 25.75±6.81 ng/ml），Sirt6（4.06±0.96 ng/ml vs 6.24±2.16 ng/ml）水平降低，差异具有统计学意义（t=11.639，10.878，均P ＜ 0.001）。Spearman 相关性分析显示，血清hTERT，Sirt6 水平与子痫前期孕妇疾病严重程度均呈负相关（r=-0.562，-0.604，均P ＜ 0.001）。ROC 曲线分析结果显示，血清hTERT，Sirt6 诊断子痫前期的曲线下面积（95% 置信区间）[AUC（95% CI）] 分别为0.711（0.673 ～ 0.747），0.727（0.689 ～ 0.762），两者联合诊断子痫前期的AUC（95%CI) 为0.788（0.753 ～ 0.820），高于两者单独诊断（Z=2.719，2.154，P=0.007，0.031）；血清hTERT，Sirt6 预测子痫前期不良妊娠结局的AUC(95%CI) 分别为0.786（0.735 ～ 0.831），0.783（0.732 ～ 0.829），两者联合预测子痫前期不良妊娠结局的AUC(95%CI) 为0.849（0.804 ～ 0.888），高于两者单独预测（Z=1.855，1.861，P=0.032，0.031）。结论 hTERT和Sirt6 在子痫前期孕妇血清中水平较低，与子痫前期孕妇疾病严重程度均呈负相关，并对妊娠结局具有一定的评估价值。
Abstract:
Objective To detect the expression of human telomerase reverse transcriptase (hTERT) and silent information regulatory factor 6 (Sirt6) in serum of pregnant women with preeclampsia, and explore the value of hTERT and Sirt6 levels in the evaluation of disease severity and pregnancy outcome. Methods A total of 300 patients with preeclampsia who were treated in Shaanxi Provincial People’s Hospital from January 2018 to December 2022 were selected as the preeclampsia group, and all pregnant women met the diagnostic criteria for preeclampsia in the Guidelines for the Diagnosis and Treatment of Hypertensive Disorders in Pregnancy (2015). Meanwhile, 300 healthy pregnant women who underwent pregnancy examinations in Shaanxi Provincial People’s Hospital during the same period were selected as the control group. Preeclampsia group was divided into mild preeclampsia group (n=180) and severe preeclampsia group (n=120) according to the severity of the disease.The preeclampsia group was divided into normal pregnancy group (n=165) and adverse pregnancy group (n=135) according to the occurrence of adverse pregnancy outcomes. Serum hTERT and Sirt6 levels were detected by enzyme-linked immunosorbent assay (ELISA). Spearman correlation analysis was applied to analyze the correlation between serum hTERT and Sirt6 levels and the severity of preeclampsia in patients. Receiver operating characteristic (ROC) curve was applied to evaluate the value of serum hTERT and Sirt6 levels in the diagnosis of preeclampsia and prediction of pregnancy outcomes. Results Compared with the control group serum levels of hTERT (22.15±5.82 ng/ml vs 30.12±9.56 ng/ml) and Sirt6 (5.26±1.62 ng/ml vs 7.06±2.29 ng/ ml) in preeclampsia group were decreased, and the differences were significant (t=12.334, 11.114, all P<0.001). Compared with the mild preeclampsia group, the serum levels of hTERT (18.28±4.11 ng/ml vs 24.73±6.96 ng/ml) and Sirt6 (4.03±1.17 ng/ml vs 6.08±1.92 ng/ml) in the severe preeclampsia group were decreased, and the differences were significant (t=9.142, 10.469, all P<0.001). Compared with the normal pregnancy group, the serum levels of hTERT (17.75±4.61 ng/ml vs 25.75±6.81 ng/ml) and Sirt6 (4.06±0.96 ng/ml vs 6.24±2.16 ng/ml) of preeclampsia pregnant women in the adverse pregnancy group were decreased, and the differences were significant (t=11.639, 10.878, all P < 0.001). Spearman correlation analysis showed that the levels of hTERT and Sirt6 in serum were negatively correlated with the severity of preeclampsia in patients (r=-0.562, -0.604, all P<0.001). ROC curve analysis results showed that the area under the curve(95% confidence interval)[AUC（95% CI）]of serum hTERT and Sirt6 in the diagnosis of preeclampsia were 0.711 (0.673 ～ 0.747) and 0.727 (0.689 ～ 0.762), respectively. The AUC（95%CI）of the combined diagnosis of preeclampsia was 0.788 (0.753~0.820), which was higher than that of the combined diagnosis of preeclampsia (Z=2.719, 2.154，P=0.007, 0.031). The AUC of serum hTERT and Sirt6 for predicting adverse pregnancy outcomes of preeclampsia were 0.786 (0.735 ～ 0.831) and 0.783 (0.732 ～ 0.829), respectively. The AUC （95% CI） of serum HTERT and Sirt6 for predicting adverse pregnancy outcomes of preeclampsia was 0.849 (0.804 ～ 0.888). It was higher than predicted by the two alone (Z=1.855, 1.861，P=0.032, 0.031). Conclusion The serum levels of hTERT and Sirt6 in pregnant women with preeclampsia were low, and they were negatively correlated with the disease severity of preeclampsia patients. They may have certain evaluation values for pregnancy outcomes.

参考文献/References:

[1] YUAN Xiangmei, CAI Leiming, HU Fengmei, et al. Evaluation of the predictive values of elevated serum L-homoarginine and dimethylarginines in preeclampsia[J]. Amino Acids, 2022, 54(8): 1215-1227.
[2] SHAHEEN G, JAHAN S, AIN Q U, et al. Placental endothelial nitric oxide synthase expression and role of oxidative stress in susceptibility to preeclampsia in Pakistani women[J]. Molecular Genetics & Genomic Medicine, 2020, 8(1): e1019.
[3] TANG Qingyun, LIU Cheng, ZHANG Shengwei, et al. FOXM1 increases hTERT protein stability and indicates poor prognosis in gastric cancer[J]. Neoplasia,2023, 36: 100863.
[4] 吴惠芬, 王晨虹. hTERT 及Caspase-3 在重度子痫前期胎盘表达的研究[J]. 中国医药指南, 2013,11(14):27-29. WU Huifen, WANG Chenhong. Expression of human telomerase reverse transcriptase in different gestational in placenta of severe preeclampsia[J]. Guide of China Medicine, 2013,11(14): 27-29.
[5] GUO Zhenyang, LI Peng, GE Junbo, et al. SIRT6 in aging, metabolism, inflammation and cardiovascular diseases[J]. Aging and Disease, 2022, 13(6): 1787-1822.
[6] 杨琼, 袁毅翀, 唐晓华. 子痫前期孕妇胎盘组织中SIRT1 和SIRT3 的表达及其与孕妇预后的相关性[J].现代医学, 2020, 48(9): 1124-1129. YANG Qiong, YUAN Yichong, TANG Xiaohua. Expression of SIRT1 and SIRT3 in placental tissues of pre-eclampsia women and its correlation with maternal prognosis[J]. Modern Medical Journal, 2020, 48(9):1124-1129.
[7] 中华医学会妇产科学分会妊娠期高血压疾病学组.妊娠期高血压疾病诊治指南(2015)[J]. 中华产科急救电子杂志, 2015, 4(4): 206-213. Hypertensive Disorders in Pregnancy Subgroup,Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Diagnosis and treatment guideline of hypertensive disorders in pregnancy (2015)[J].Chinese Journal of Obstetric Emergency(Electronic Edition), 2015, 4(4): 206-213.
[8] FANTONE S, MAZZUCCHELLI R, GIANNUBILO S R, et al. AT-rich interactive domain 1A protein expression in normal and pathological pregnancies complicated by preeclampsia[J]. Histochemistry and Cell Biology, 2020, 154(3): 339-346.
[9] 危丽华, 张新, 封伟. 子痫前期孕妇血清SOCS3,PP-13, GATA-3 水平变化及其预测价值研究[J]. 现代检验医学杂志, 2022, 37(1): 48-51, 87. WEI Lihua, ZHANG Xin, FENG Wei. Changes of serum SOCS3, PP-13 and GATA-3 levels in preeclampsia and their predictive value[J]. Journal of Modern Laboratory Medicine, 2022, 37(1): 48-51, 87.
[10] CROKE L. Gestational hypertension and preeclampsia:a practice bulletin from ACOG[J]. American Family Physician, 2019, 100(10): 649-650.
[11] AGRAWAL S, CERDEIRA A S, REDMAN C, et al. Meta-analysis and systematic review to assess the role of soluble FMS-like tyrosine kinase-1 and placenta growth factor ratio in prediction of preeclampsia: the SaPPPhirE study[J]. Hypertension, 2018, 71(2): 306-316.
[12] STEPAN H, HUND M, ANDRACZEK T. Combining biomarkers to predict pregnancy complications and redefine preeclampsia: the angiogenic-placental syndrome[J]. Hypertension, 2020, 75(4): 918-926.
[13] HE Andong, ZHOU Yixuan, WEI Yiling, et al. Potential protein biomarkers for preeclampsia[J]. Cureus, 2020,12(6): e8925.
[14] 林娟. 人端粒酶逆转录酶在子痫前期胎盘表达的研究[D]. 广州：南方医科大学, 2012. LIN Juan. The expression of the human telomerase reverse transcriptase in preeclampsia placenta[D].Guangzhou: Southern Medical University,2012.
[15] 葛瀛洲, 刘欣梅, 黄荷凤. 沉默信息调节因子家族参与病理妊娠的研究进展[J]. 浙江大学学报(医学版）,2021, 50(3): 335-344. GE Yingzhou, LIU Xinmei, HUANG Hefeng. Advances in the role of silence information regulator family in pathological pregnancy[J]. Journal of Zhejiang University (Medical Sciences), 2021, 50(3): 335-344.
[16] 林娟, 王晨虹, 许多. 重度子痫前期患者胎盘组织hTERT 和bFGF 的表达及意义[J]. 华南国防医学杂志, 2012, 26(1): 36-39. LIN Juan, WANG Chenhong, XU Duo. Expression and significance of hTERT and bFGF in placental tissue of patients with severe preeclampsia[J]. Military Medical Journal of South China, 2012, 26(1): 36-39.
[17] 王海娇, 王毅, 崔玉娇, 等. 环状RNA UBAP2 和环状RNA VRK1 在子痫前期患者血清中的表达及其与妊娠结局的关系[J]. 中国性科学, 2023, 32(6): 95-99. WANG Haijiao, WANG Yi, CUI Yujiao, et al. Expression of circular RNA UBAP2 and circular RNA VRK1 in serum of patients with preeclampsia and their relationship with pregnancy outcome[J]. Chinese Journal of Human Sexuality, 2023, 32(6): 95-99.
[18] GE Juan, LI Congyang, LI Chunling, et al. SIRT6 participates in the quality control of aged oocytes via modulating telomere function[J]. Aging (Albany NY),2019, 11(7): 1965-1976.
[19] 周冰皓, 邱菊, 田艳杰, 等.MiR-34a 和SIRT1 在子痫前期患者胎盘中的表达及意义[J]. 河北医药,2020, 42(8):1144-1147. ZHOU Binghao, QIU Ju, TIAN Yanjie, et al. Expressions and significance of miR-34a and SIRT1 in placenta of patients with preeclampsia [J]. Hebei Medical Journal, 2019, 42(8): 1144-1147.
[20] 但家欣. SIRT3 表达降低导致滋养细胞凋亡增加在子痫前期发病中的作用[D]. 重庆：重庆医科大学,2019. DAN Jiaxin. Reduced expression of SIRT3 leads to increased apoptosis of trophoblasts in the pathogenesis of preeclampsia [D]. Chongqing: Chongqing Medical University,2019.
[21] YU Yingchun, AN Xiaoqin, FAN Dongmei. Histone deacetylase sirtuin 2 enhances viability of trophoblasts through p65-mediated microRNA-146a/ACKR2 axis[J]. Reproductive Sciences, 2021, 28(5): 1370-1381.

相似文献/References:

[1]仇秋明,赵英伦.子痫前期患者血清中TFAR19活性研究[J].现代检验医学杂志,2015,30(02):68.[doi:10.3969/j.issn.1671-7414.2015.02.021]
　QIU Qiu-ming,ZHAO Ying-lun.Serum TFAR19 Activity in Preeclampsia Patients[J].Journal of Modern Laboratory Medicine,2015,30(03):68.[doi:10.3969/j.issn.1671-7414.2015.02.021]
[2]郭进京.孕中期母血PAPPA与PIGF在预测子痫前期发生的作用[J].现代检验医学杂志,2016,31(05):115.[doi:10.3969/j.issn.1671-7414.2016.05.032]
　GUO Jin-jing.Role of Maternal PAPPA and PIGF Levels at Second Trimester in the Prediction of Preeclampsia[J].Journal of Modern Laboratory Medicine,2016,31(03):115.[doi:10.3969/j.issn.1671-7414.2016.05.032]
[3]王秀珍,李连友,王秀梅.子痫前期患者血清中PDGF-BB和U-Ⅱ检测的临床价值[J].现代检验医学杂志,2016,31(06):82.[doi:10.3969/j.issn.1671-7414.2016.06.023]
　WANG Xiu-zhen,LI Lian-you,WANG Xiu-mei.Clinical Value of Serum PDGF-BB and U-Ⅱ in Patients with Preeclampsia[J].Journal of Modern Laboratory Medicine,2016,31(03):82.[doi:10.3969/j.issn.1671-7414.2016.06.023]
[4]甘 露a,刘西玲b,王 婷c,等.子痫前期患者血清及尿液中miR-125a/b-5p的表达及相关临床研究[J].现代检验医学杂志,2017,32(06):32.[doi:10.3969/j.issn.1671-7414.2017.06.001]
　GAN Lua,LIU Xi-lingb,WANG Tingc,et al.Expression of miR-125a/b-5p in Serum and Urine of Preeclampsia and Related Clinical Studies[J].Journal of Modern Laboratory Medicine,2017,32(03):32.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[5]吕艳关,王丽,赵玉杰.子痫前期患者血清PCT,HSP9及hs-CRP检测的临床意义[J].现代检验医学杂志,2018,33(04):83.[doi:10.3969/j.issn.1671-7414.2018.04.022]
　LV Yan-guan,WANG Li,ZHAO Yu-jie.Clinical Significance of Detecting Serum PTC,HSP90 and hs-CRP in Patients with Pre-Eclamptic L[J].Journal of Modern Laboratory Medicine,2018,33(03):83.[doi:10.3969/j.issn.1671-7414.2018.04.022]
[6]崔普芳,刘爱胜,李　喆,等.深圳龙华区孕妇血清维生素Ｄ水平及其受体基因rs2228570多态性与子痫前期易感性相关性研究[J].现代检验医学杂志,2021,36(05):23.[doi:10.3969/j.issn.1671-7414.2021.05.005]
　CUI Pu-fanga,LIU Ai-shengb,LI Zhea,et al.Study on the Correlation between Serum Vitamin D Level and rs2228570Polymorphism of Its Receptor Gene and Preeclampsia Susceptibility inPregnant Women in Shenzhen Longhua District[J].Journal of Modern Laboratory Medicine,2021,36(03):23.[doi:10.3969/j.issn.1671-7414.2021.05.005]
[7]崔普芳,龚　源,刘爱胜,等.深圳地区妊娠期子痫前期孕妇血清中IL-22，IL-17，IL-10，TGF-β水平表达及IL-22基因rs2227485T/C位点多态性分析[J].现代检验医学杂志,2021,36(06):55.[doi:10.3969/j.issn.1671-7414.2021.06.011]
　CUI Pu-fang,GONG Yuan,LIU Ai-sheng,et al.Expression of Serum Levels of IL-22, IL-17, IL-10 and TGF-β in Pregnant Women with Preeclampsia During Pregnancy and Polymorphism Analysis of IL-22 Gene rs2227485 T/C Locus in Shenzhen Area[J].Journal of Modern Laboratory Medicine,2021,36(03):55.[doi:10.3969/j.issn.1671-7414.2021.06.011]
[8]薛　伟a,易福凌,王　苗b,等.孕妇血清亲环素A和组织型转谷氨酰胺酶水平检测与子痫前期发生不良妊娠的相关性研究[J].现代检验医学杂志,2021,36(06):78.[doi:10.3969/j.issn.1671-7414.2021.06.016]
　XUE Wei,YI Fu-ling,WANG Miao,et al.Correlation Research between Serum Levels of Cyclophilin A as Well as Tissue Transglutaminase in Pregnant Women and Adverse Pregnancy in Preeclampsia[J].Journal of Modern Laboratory Medicine,2021,36(03):78.[doi:10.3969/j.issn.1671-7414.2021.06.016]
[9]于　艳,白青山,才蔚涛.子痫前期并发幽门螺旋杆菌感染患者血清 miR-31-5p表达与不良妊娠结局的相关性研究[J].现代检验医学杂志,2022,37(01):17.[doi:10.3969/j.issn.1671-7414.2022.01.004]
　YU Yan,BAI Qing-shan,CAI Wei-tao.Correlation between Serum miR-31-5p Expression and Adverse Pregnancy Outcomes in Patients with Preeclampsia Complicated with Helicobacter Pylori Infection[J].Journal of Modern Laboratory Medicine,2022,37(03):17.[doi:10.3969/j.issn.1671-7414.2022.01.004]
[10]危丽华a,张　新a,封　伟b.子痫前期孕妇血清 SOCS3，PP-13，GATA-3水平变化及其预测价值研究[J].现代检验医学杂志,2022,37(01):48.[doi:10.3969/j.issn.1671-7414.2022.01.010]
　WEI Li-huaa,ZHANG Xina,FENG Weib.Changes of Serum SOCS3, PP-13 and GATA-3 Levels in Preeclampsia and Their Predictive Value[J].Journal of Modern Laboratory Medicine,2022,37(03):48.[doi:10.3969/j.issn.1671-7414.2022.01.010]

备注/Memo

备注/Memo:
基金项目：陕西省自然科学基础研究计划项目（课题编号：2020JQ-937）。
作者简介：张雅（1981-），女，硕士研究生，副主任医师，研究方向：子痫临床研究,E-mail：fznbvxo@163.com。
通讯作者：刘晓红（1971-），女，本科，副主任医师，研究方向：产科难产及危重症处理，E-mail：minhou2115@163.com。
更新日期/Last Update: 2024-05-15